Straumann Holding AGXSWX:STMN +1.81%99 Days Inventory is 194.09 as of Dec. 2025, which is 3% above its 10-year median of 188.01. GuruFocus rates XSWX:STMN with a GF Score™ of 99/100 and a GF Value™ of CHF136.92 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Straumann Holding AG ranks worse than 58.78% on this metric.
The historical rank and industry rank for Straumann Holding AG's Days Inventory or its related term are showing as below:
XSWX:STMN'
s Days Inventory Range Over the Past 10 Years
Min: 163.32 Med: 188.01 Max: 214.25
Current: 203.27
During the past 13 years, Straumann Holding AG's highest Days Inventory was 214.25. The lowest was 163.32. And the median was 188.01.
XSWX:STMN's Days Inventory is ranked worse than 58.78% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.86
vs XSWX:STMN: 203.27
Straumann Holding AG's Days Inventory
declined
from Dec. 2024 (209.43) to Dec. 2025 (194.09).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Straumann Holding AG's Inventory Turnover for the
six
months ended in Dec. 2025 was 0.94.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Straumann Holding AG's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.37.
Straumann Holding AG (XSWX:STMN) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Straumann Holding AG's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Straumann Holding AG's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Straumann Holding AG Days Inventory Related Terms
Straumann Holding AG Days Inventory Historical Data
* Premium members only.
The historical data trend for Straumann Holding AG's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:STMN vs ISRG, BDX, MDLN: Days Inventory Comparison
For the Medical Instruments & Supplies subindustry, Straumann Holding AG's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Straumann Holding AG Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Straumann Holding AG's Days Inventory distribution charts can be found below:
* The bar in red indicates where Straumann Holding AG's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Straumann Holding AG (XSWX:STMN) has a Days Inventory of 194.09 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Straumann Holding AG and its competitors. This is near median its historical median of 188.01. Over the past decade, Straumann Holding AG's Days Inventory has ranged from 163.32 to 214.25. According to the industry distribution chart, Straumann Holding AG ranks #462 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 58.8%.
Is Straumann Holding AG's Days Inventory too high?
Straumann Holding AG's current Days Inventory of 194.09 is near median its 10-year median of 188.01. Over the past 10 years, this metric has ranged from a low of 163.32 to a high of 214.25. The Medical Devices & Instruments industry median Days Inventory is 179.86. Straumann Holding AG's value of 194.09 is 7.9% above this industry median. Based on the distribution chart, Straumann Holding AG ranks #462 out of 786 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Straumann Holding AG has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Straumann Holding AG's Days Inventory compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Straumann Holding AG ranks #462 out of 786 companies for Days Inventory. This places Straumann Holding AG in the lower half of its industry. The industry median Days Inventory is 179.86. Straumann Holding AG's value of 194.09 is 7.9% above this benchmark. Historically, Straumann Holding AG's own Days Inventory has ranged from 163.32 to 214.25 over the past decade. While the company's 10-year median is 188.01 vs. the industry median of 179.86, Straumann Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.86, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Straumann Holding AG's current Days Inventory of 194.09 is 7.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Straumann Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Straumann Holding AG's current Days Inventory is 194.09, which is near median its own 10-year median of 188.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Straumann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Straumann Holding AG (XSWX:STMN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF136.92, compared to a current price of CHF106.80 — trading 22% below its estimated fair value. The current Days Inventory is 194.09, which is near median its 10-year median of 188.01 and 7.9% above the Medical Devices & Instruments industry median of 179.86. Straumann Holding AG's overall GF Score™ is 99/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Straumann Holding AG (XSWX:STMN), the current Days Inventory is 194.09 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Straumann Holding AG (XSWX:STMN) Overvalued in 2026?
Based on GuruFocus' analysis, Straumann Holding AG stock appears to be undervalued.
The current stock price of CHF106.80 is trading 22% below its estimated GF Value™ of CHF136.92.
GuruFocus considers Straumann Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:STMN:
Days Inventory: 194.09 (near median its 10-year median of 188.01)
GF Value™: CHF136.92 vs. price of CHF106.80 (22% below fair value)
Industry Position: 7.9% above the Medical Devices & Instruments median (#462 of 786)
No single metric tells the full story. See the XSWX:STMN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it holds over one third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.
99GF Score
Get the complete analysis for XSWX:STMN
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:STMN has been successfully added to your 
